Ignite Creation Date:
2024-07-17 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492148
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-11
Brief Title:
Myofascial Release Technique in Women With Primary Dysmenorrhea
Sponsor:
Gazi University
Organization:
Gazi University
Study Overview
Official Title:
Effect of Myofascial Release Technique on Central Sensitization Myofascial Trigger Point and Menstrual Symptoms in Women With Primary Dysmenorrhea Sham-Controlled Randomized Double-Blind Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It has been found that women with dysmenorrhea have active trigger points particularly in the rectus abdominis oblique abdominal muscles quadratus lumborum and paraspinal muscles The myofascial release technique is a widely used manual therapy method characterized by the application of low-load long-duration mechanical forces to manipulate the myofascial complex This technique aims to restore optimal length alleviate pain and improve function This study aims to examine the effect of the myofascial release technique on central sensitization myofascial trigger points and menstrual symptoms in women with primary dysmenorrhea
Detailed Description:
During the evaluation period the participants musculoskeletal pain threshold and tolerance will be measured using an algometer about trigger points on the identified muscles rectus abdominis quadratus lumborum erector spinae and tibialis anterior A total of 40 women aged 18-40 diagnosed with primary dysmenorrhea by a gynecologist will be included in the study The initial assessment of the participants will be conducted on their most painful days Participants will be randomized into two groups the myofascial release technique group study group and the placebo myofascial release technique group control group The interventions will be conducted over 10 sessions during one menstrual cycle and all evaluations will be repeated after the treatment period The study will be conducted as a double-blind trial ensuring that both the evaluators and the patients are blind to the group assignments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None